View Single Post
Old 03-21-2016, 09:21 PM
zanpar321 zanpar321 is offline
Member
 
Join Date: Feb 2014
Posts: 365
10 yr Member
zanpar321 zanpar321 is offline
Member
 
Join Date: Feb 2014
Posts: 365
10 yr Member
Default

[QUOTE=Tupelo3;1205347]
Quote:
Originally Posted by ashleyk View Post
There have been posts here on Nilotnlib earlier. This is an FDA approved drug for cancer and it has been shown to work, at lower doses, for PD to clear out c-Abl activity. Does Michael Fox know about this?

Yes, MJFF knows about this small trial, as do all of the other major funding organizations and most people in the PD community. Unfortunately, with all of the publicity this trial received, the research team has yet to secure funding to begin a larger, controlled, phase 2 study. I have heard any number of reasons for the lack of interest and $, but who knows what the truth really is.
This seems to be the latest on the Nilotinib trial. " the second phase of the Nilotinib trial. It's scheduled to start this summer and has funding"

http://neurotalk.psychcentral.com/ar.../t-220156.html
zanpar321 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
GerryW (03-22-2016)